Moolec Science (MLEC) Amortization - Intangibles (2023 - 2024)
Moolec Science (MLEC) reported Amortization - Intangibles of -$131756.0 for Q3 2024, up 4.6% on a YoY basis from -$125960.1 in Q4 2023, and up 0.81% sequentially from -$132826.0 in Q1 2024.
Moolec Science (MLEC) Amortization - Intangibles (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of Amortization - Intangibles data on file, last reported at -$131756.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -131,756.00 |
| Mar 31, 2024 | -132,826.00 |
| Dec 31, 2023 | -142,218.00 |
| Sep 30, 2023 | -138,111.00 |